Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 192 of 5804
-
New surgical trick may stop chronic pain after breast cancer surgery
Prevention Not yet recruitingRegenerative peripheral nerve interface (RPNI) was first developed in 2012 by Dr. Paul Cederna at the University of Michigan as a means for amputees to control their prothesis with their minds. In the decade that followed, it was found RPNI surgery not only provided amputees with…
Phase: NA • Sponsor: George Kokosis • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
Could MDMA help heal healthcare Heroes' hidden wounds?
Symptom relief Not yet recruitingThe purpose of this study is to assess the safety and efficacy of MDMA-Assisted Therapy on Frontline Health Care Workers and First Responders suffering from symptoms of Post-Traumatic Stress.
Phase: PHASE2 • Sponsor: Nautilus Sanctuary • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New infusion drug aims to keep severe heart failure patients out of hospital
Disease control Not yet recruitingThis is a global multicenter, doubleblind, placebo-controlled, randomized, parallel-group study that compares ALP-1 given in a continuous infusion ( compared to placebo), 250mcg/day on majore outcomes up to 6 months after randomization in participants with advanced HF with reduce…
Phase: PHASE3 • Sponsor: Biopeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a pill and a coach beat teen obesity? massive new study aims to find out.
Disease control Not yet recruitingThe rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role h…
Phase: PHASE4 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a diabetes drug boost heart ablation success?
Disease control Not yet recruitingTo evaluate whether pre-treatment with semaglutide is superior to standard care in improving freedom from atrial fibrillation (AF) at 12 months following catheter ablation in patients with obesity and symptomatic AF undergoing first-time ablation.
Phase: PHASE4 • Sponsor: University of Luebeck • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New personalized safety plan aims to save Veterans' lives after hospital discharge
Symptom relief Not yet recruitingVeterans psychiatrically hospitalized face significantly elevated suicide risk, particularly in the three months post-discharge. While Safety Planning is a required component of discharge planning, many safety plans lack personalization thereby reducing their effectiveness. The p…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Blood test may let some throat cancer patients skip radiation after surgery
Disease control Recruiting nowThis single-arm Phase II trial evaluates whether omission of postoperative radiotherapy is feasible and oncologically safe in select patients with HPV-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). Eligible patients undergo transoral robotic surgery (TORS) and are …
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThe purpose of this study is to assess the therapeutic efficacy of mosunetuzumab, a bispecific antibody targeting CD20 and CD3 in patients who have detectable chronic lymphocytic leukemia (CLL) after receiving Bruton's tyrosine kinase inhibitors (BTKis) for at least 6 months and …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Promising new combo aims to tame hodgkin lymphoma in young patients
Disease control Not yet recruitingThe goal of this clinical research study is to learn if nivolumab plus AVD (doxorubicin, vinblastine, and dacarbazine) can help to control newly diagnosed early-stage non-bulky cHL in pediatric, adolescent, and young adult patients. The safety of this drug combination will also …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Newborn infection shield: taurolidine lock tested in 576 babies
Prevention Not yet recruitingFor newborns admitted to Neonatal Intensive Care Units (NICUs), one of the main risk factors for late-onset sepsis is the presence of a central venous catheter (CVC), which is often essential for the administration of medications and parenteral nutrition in this patient populatio…
Phase: NA • Sponsor: University of Turin, Italy • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New combo aims to shrink tough colon cancers before surgery
Disease control Not yet recruitingIn patients with high-risk stage II and stage III colon cancer, curative surgery followed by adjuvant chemotherapy with FOLFOX or CAPOX regimens has become the standard treatment. However, 20 to 30% of these patients will develop distant metastasis, which ultimately results in de…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Liver cancer radiation therapy may open door to transplant
Disease control Not yet recruitingThis clinical investigation involves the use of an approved medical device (SIR-Spheres®) for a new purpose in patients with certain types of liver cancer. The goal is to determine whether this treatment can help patients qualify for or maintain eligibility for a liver transplant…
Phase: PHASE2 • Sponsor: Sirtex Medical • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New scan spots hidden organ damage before symptoms start
Diagnosis Not yet recruitingThe goal of this clinical trial is to evaluate whether ¹⁸F-florbetaben PET/MR can detect systemic amyloid deposits early and noninvasively in patients with monoclonal gammopathy. The main question it aims to answer is: Can ¹⁸F-florbetaben PET/MR identify systemic amyloid deposits…
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Freezing breast tumors: a new hope for metastatic cancer control?
Disease control Not yet recruitingMetastatic breast cancer remains an incurable disease for most patients. While surgical treatment of the primary breast tumor is commonly performed in localized breast cancer, its role in metastatic breast cancer remains controversial due to the lack of demonstrated survival bene…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a smartphone app replace the gym for diabetes control?
Disease control Not yet recruitingType 2 diabetes (T2D) and obesity are two of the most common chronic conditions worldwide, and they frequently occur together. Both conditions are closely linked to physical inactivity, which is currently recognized as a major risk factor for a wide range of diseases. Although st…
Phase: NA • Sponsor: Escuela Universitaria de Osuna • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a new drug replace steroids for brain tumor swelling?
Disease control Not yet recruitingThe purpose of this study is to learn whether two alternatives to standard steroid treatment can safely control swelling around a brain tumor after surgery. The study will compare three approaches by placing participants in one of three study groups: standard dexamethasone (a ste…
Phase: PHASE2 • Sponsor: Akshitkumar MIstry • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Radioactive beads take aim at brain tumours
Disease control Not yet recruitingThis study is testing a new way of treating brain tumours using tiny radioactive beads called SIR-Spheres® (90Y-labelled Resin Microspheres). These microspheres are placed into the blood vessels that feed the tumour. The treatment gives off radiation inside the tumour to try to s…
Phase: EARLY_PHASE1 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a Low-Dose antipsychotic ease long COVID brain fog?
Symptom relief Not yet recruitingPost-acute infectious syndrome (PAIS), including post-COVID-19 condition (PCC or Long COVID), can develop after an infection and may cause persistent symptoms such as fatigue, problems with memory and concentration ("brain fog"), mood changes, and reduced quality of life. In some…
Phase: PHASE2 • Sponsor: Christiana Franke • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Experimental drug targets rare genitourinary cancers in new trial
Disease control Not yet recruitingRINGQUEST is a Phase 2, open-label, single arm, basket, investigator-initiated clinical trial of sacituzumab tirumotecan in patients with: * Cohort 1: papillary renal carcinoma (pRCC). * Cohort 2: less frequent bladder tumors such as variant histology urothelial carcinoma (VH-UC…
Phase: PHASE2 • Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Rewiring the brain to silence chronic pain — a bold psychological therapy is put to the test
Symptom relief Not yet recruitingThis study examines the effectiveness of a brief psychological intervention for chronic pain treatment, as well as the psychological and neurophysiological mechanisms associated with changes in pain intensity. Participants with chronic pain will be randomly assigned to one of th…
Phase: NA • Sponsor: Ben-Gurion University of the Negev • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC